Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Ciprofloxacin (AN)

Ciprofloxacin (AN) is a medicine containing the active ingredient(s) ciprofloxacin. On this page you will find out more about Ciprofloxacin (AN), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: ciprofloxacin

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Ciprofloxacin (AN) 750 mg film-coated tablet, 14

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Ciprofloxacin is indicated for the treatment of infections caused by susceptible organisms in the conditions listed below: Urinary tract infections; Gonorrhoeal urethritis and cervicitis; Gastroenteritis; Bronchial Infections; Skin and skin structure infections; Bone and joint infections; Chronic bacterial prostatitis of mild to moderate severity. Inhalational anthrax (post-exposure): To reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis. Ciprofloxacin serum concentrations achieved in humans serve as a surrogate endpoint reasonably likely to predict clinical benefit and provide the basis for this indication. Note: Typhoid and Paratyphoid infections and infections due to multi-resistant Staphylococcus aureus are excluded from the above due to insufficient data. Because Gram-positive organisms are generally less sensitive to ciprofloxacin, it may not be the drug of choice in cases with Gram-positive infections, such as pneumonia due to Streptococcus pneumoniae. Chronic bacterial prostatitis should be demonstrated by microbiological evidence localising infection to the prostate. Strains of Neisseria gonorrhoea resistant to ciprofloxacin have been reported in Australia. Appropriate culture and susceptibility tests should be performed before treatment in order to determine organism susceptibility to ciprofloxacin and after treatment as warranted by the clinical condition. Therapy with Ciprofloxacin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. Ciprofloxacin is suitable to treat mixed infections caused by susceptible strains of both Gram-negative and Gram-positive aerobic bacteria. If anaerobic organisms are suspected as accompanying aetiologic agents, additional therapy should be considered.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance White to off-white, capsule shaped, film coated tablets debossed with 'C' on one side and '93' on the other side
Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
14: Prescription Only Medicine, or Prescription Animal Remedy
28: Prescription Only Medicine, or Prescription Animal Remedy
60: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Blister Pack
Storage temperature Store below 25 degrees Celsius
Storage conditions No information available
Life time 3 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 139 results

Ciprofloxacin Tablets - myDr.com.au

Ciprofloxacin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Ciprofloxacin AN Tablets - myDr.com.au

Ciprofloxacin AN Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Ciprofloxacin Sandoz Tablets - myDr.com.au

Ciprofloxacin Sandoz Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

GenRx Ciprofloxacin Tablets - myDr.com.au

GenRx Ciprofloxacin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Ciprofloxacin-BC | myVMC

Ciprofloxacin hydrochloride is used to treat a range of bacterial infections. It is a synthetic, broad-spectrum, quinolone antibiotic.

Read more on myVMC – Virtual Medical Centre website

Ciprofloxacin Alphapharm Solution for infusion - myDr.com.au

Ciprofloxacin Alphapharm Solution for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

DBL Ciprofloxacin Injection For Intravenous Infusion - myDr.com.au

DBL Ciprofloxacin Injection For Intravenous Infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Aspen Ciprofloxacin Injection for Intravenous Infusion - myDr.com.au

Aspen Ciprofloxacin Injection for Intravenous Infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Ciproxin IV (Ciprofloxacin lactate) information | myVMC

Ciproxin IV is an intravenously administered antibiotic used to treat severe infection in hospitalised patients. It contains ciprofloxacin lactate.

Read more on myVMC – Virtual Medical Centre website

Ciloxan | myVMC

Ciloxan is an ointment containing ciprofloxacin hydrochloride used to treat bacterial eye infections including keratitis and bacterial conjunctivitis.

Read more on myVMC – Virtual Medical Centre website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback